Current Multiple Myeloma Treatment Strategies with Novel Agents: A European Perspective

The treatment of multiple myeloma (MM) has undergone significant developments in recent years. The availability of the novel agents thalidomide, bortezomib, and lenalidomide has expanded treatment options and has improved the outcome of patients with MM. Following the introduction of these agents in...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Ludwig, Heinz, Beksac, Meral, Bladé, Joan, Boccadoro, Mario, Cavenagh, Jamie, Cavo, Michele, Dimopoulos, Meletios, Drach, Johannes, Einsele, Hermann, Facon, Thierry, Goldschmidt, Hartmut, Harousseau, Jean-Luc, Hess, Urs, Ketterer, Nicolas, Kropff, Martin, Mendeleeva, Larisa, Morgan, Gareth, Palumbo, Antonio, Plesner, Torben, San Miguel, Jesús, Shpilberg, Ofer, Sondergeld, Pia, Sonneveld, Pieter, Zweegman, Sonja
التنسيق: Artigo
اللغة:Inglês
منشور في: AlphaMed Press 2010
الموضوعات:
Academia–Pharma Intersect
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC3227886/
https://ncbi.nlm.nih.gov/pubmed/20086168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2009-0203
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة